Recruiting NA INTERVENTIONAL 1-arm
NCT06861075
CARPEUS : Effect of Carvedilol on the Portosystemic Gradient as Measured by Endoscopic Ultrasound (CARPEUS)
Sponsor: University Hospital, Clermont-Ferrand
Interventions
Carvedilol
Updated 2 times since 2025 Last updated: Sep 17, 2025 Started: Apr 16, 2025 Primary completion: Mar 1, 2028 Completion: Apr 1, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This NA trial investigates Cirrhosis and Portal Hypertension Related to Cirrhosis and is currently actively recruiting participants. University Hospital, Clermont-Ferrand leads this study, which shows 2 recorded versions since 2025 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
2 versions recorded-
Oct 2025 — Present [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Apr 2025 — Oct 2025 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- University Hospital, Clermont-Ferrand
Data source: University Hospital, Clermont-Ferrand
For direct contact, visit the study record on ClinicalTrials.gov .